Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Roeselare, Australia Clinical Trials

A listing of Roeselare, Australia clinical trials actively recruiting patients volunteers.

RESULTS

Found (6) clinical trials

A research study is evaluating the combination of one investigational medication with two FDA-approved medications for high cholesterol. This research study may be an option if you: Are at least 18 years of age or older Have a history of elevated LDL (“bad” cholesterol) levels Are able to stop use ...

Phase N/A

A phase 3 research study of an oral investigational medication as induction and maintenance therapy for adults ages 18 to 75 with moderate to severe ulcerative colitis. Note, study participants may receive the investigational medication or placebo. For more information, please visit our study website at: www.TrueNorthStudy.com

Phase

This research study is for people with advanced liver cancer who have never received systemic medicine (affecting the entire body) for advanced liver cancer. This is a randomized, open-label Phase 3 study to determine whether treatment with vaccinia virus based immunotherapy (Pexa-Vec) followed by sorafenib can slow the progression of ...

Phase

Computer-Assisted Hair Implantation Using ARTAS System VS Manual Implantation Technique Hair Restoration Study

This comparative study is a multi-center, prospective, blinded, randomized controlled clinical study where subjects act as their own control. The purpose of this study is to demonstrate that the ARTAS System is safe and effective for implanting follicular hair units. Patients will be followed for a nine months period of ...

Phase N/A

Trial of An Innovative Smartphone Intervention for Smoking Cessation

The goal of this study is to determine whether the novel smartphone app (SmartQuit) provides higher quit rates than the current standard smoking cessation app.

Phase N/A

Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants

Bone marrow CD34+ cells will be obtained in the operating room, transduced with the lentiviral vector that contains a normal copy of the c gene, and reinfused without any myeloreductive conditioning. Participants will be monitored for hematopoietic recovery from busulfan and for severe adverse events for 42 days. The primary ...

Phase